A deep-learning method can cut brain MRI time for spotting new MS lesions by about half while finding the same new spots as the standard scan.
Researchers compared a standard 3D MRI scan that takes about 5 minutes with a deep-learning (computer-trained) version that takes about 2 minutes 48 seconds. The faster scan found new white matter lesions just as well as the standard scan for most brain areas, using a certified software tool to count lesions. Agreement between the two scans was very high, meaning they usually matched on whether new lesions were present. Some readers thought the standard scan images looked a bit clearer and gave slightly more confidence for diagnosis. Overall, the faster scan is nearly interchangeable with the standard one but may trade a little image sharpness for big time savings.
People with MS and their caregivers should care because shorter MRI scans mean less time in the machine and more comfortable visits. Clinicians and MRI centers can add more tests or checks during the same visit because the fast scan frees up time, like fitting another short tool into a toolbox. The fast scan still finds new MS-related lesions, so it can help track disease activity and guide treatment choices without losing important information. Caregivers can expect quicker appointments and potentially fewer missed work or travel disruptions. MRI technologists and doctors should know the fast option may need a small drop in speed if they want the very best image quality.
The study was done on 94 people at one magnetic strength (1.5T), so results might differ at other hospitals or with other machines. Some experts rated the older scan as a bit clearer, so in tricky cases doctors might prefer the standard scan or use a slightly slower deep-learning setting. This study used certified lesion-counting software, but real-world practices vary, so talk with your care team before switching scan types.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/31/2026
Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response
Read More9/1/2026
A small study found Ma/Ma2 antibodies can cause nerve-only symptoms often linked to cancer; testing
Read More7/4/2026
Researchers mapped CSF1R-positive microglia in the brain and found white-matter increases in progres
Read More7/4/2026
Study links a mucus-eating gut microbe to other bacteria that turn tryptophan into molecules that fu
Read More7/4/2026
Review finds physical training and motor learning may boost myelin repair in MS; combining exercise,
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Investigative radiology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.